Literature DB >> 2421863

Insulin allergy.

L Grammer.   

Abstract

While immunologic responses to insulin such as cutaneous reactivity and antibody against insulin are common significant clinical problems related to those immunologic reactions are uncommon. Immunologic responses that have been described included Gell and Coombs type I, II, and IV. The antigen may be the result of any of several factors: insulin as a heterologous protein, altered tertiary structure of insulin, presence of non-insulin protein contaminants, or pharmaceutical formulation additives. IgE mediated local reactions are the most common and almost always subside spontaneously. IgE mediated anaphylaxis is the most important immunologic problem; it can be managed safely and successfully by temporary reduction in dose or by insulin desensitization. Other systemic immunologic reactions, insulin resistance and serum sickness, are extremely rare and respond to corticosteroid therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2421863     DOI: 10.1007/bf02991108

Source DB:  PubMed          Journal:  Clin Rev Allergy        ISSN: 0731-8235


  41 in total

1.  Single-peak insulin in the treatment of insulin-induced fat atrophy.

Authors:  L Ferland; R M Ehrlich
Journal:  J Pediatr       Date:  1975-05       Impact factor: 4.406

2.  The incidence of skin reactivity to insulin in diabetic patients.

Authors:  J A ARKINS; N H ENGBRING; E J LENNON
Journal:  J Allergy       Date:  1962 Jan-Feb

3.  Protamine as a cause of generalised allergic reactions to NPH insulin.

Authors:  M B Sánchez; M Paolillo; R S Chacón; M Camejo
Journal:  Lancet       Date:  1982-05-29       Impact factor: 79.321

4.  Cutaneous complications of chronic continuous subcutaneous insulin infusion therapy.

Authors:  A Pietri; P Raskin
Journal:  Diabetes Care       Date:  1981 Nov-Dec       Impact factor: 19.112

5.  Human insulin allergy.

Authors:  P Small; S Lerman
Journal:  Ann Allergy       Date:  1984-07

6.  Severe delayed inflammatory reactions from injected insulin. Association with cell-mediated immunity.

Authors:  W B White; S A DeMartino; T Yoshida
Journal:  Am J Med       Date:  1983-05       Impact factor: 4.965

7.  Insulin allergy and insulin resistance. Case report with immunologic studies.

Authors:  J Dolovich; J D Schnatz; R E Reisman; Y Yagi; C E Arbesman
Journal:  J Allergy       Date:  1970-09

8.  Immediate-type allergy against insulin itself: clinical and immunologic studies on a diabetic patient with insulin intolerance.

Authors:  G Schernthaner; H Ludwig; R Jarisch; H Bruneder
Journal:  Diabetes Care       Date:  1981 Mar-Apr       Impact factor: 19.112

9.  IgE and IgG antibody against human (recombinant DNA) insulin in patients with systemic insulin allergy.

Authors:  L C Grammer; M Roberts; R Patterson
Journal:  J Lab Clin Med       Date:  1985-01
View more
  3 in total

1.  Clinical utility of insulin and insulin analogs.

Authors:  Ahter D Sanlioglu; Hasan Ali Altunbas; Mustafa Kemal Balci; Thomas S Griffith; Salih Sanlioglu
Journal:  Islets       Date:  2013-03-01       Impact factor: 2.694

Review 2.  Allergic reactions to human insulin: a review of current knowledge and treatment options.

Authors:  Baris Akinci; Serkan Yener; Firat Bayraktar; Sena Yesil
Journal:  Endocrine       Date:  2009-10-30       Impact factor: 3.633

Review 3.  Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients.

Authors:  Xiaolei Hu; Fengling Chen
Journal:  Endocr Connect       Date:  2017-12-12       Impact factor: 3.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.